Philipp Foessleitner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaginosis, Bacterial | 3 | 2023 | 151 | 1.590 |
Why?
|
Premature Birth | 6 | 2023 | 1784 | 1.190 |
Why?
|
Dequalinium | 1 | 2023 | 7 | 0.920 |
Why?
|
Vulvovaginitis | 1 | 2023 | 14 | 0.910 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2023 | 25 | 0.900 |
Why?
|
Anti-Infective Agents, Local | 1 | 2023 | 247 | 0.750 |
Why?
|
Vagina | 3 | 2021 | 841 | 0.700 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2020 | 137 | 0.630 |
Why?
|
Klebsiella Infections | 1 | 2020 | 144 | 0.620 |
Why?
|
Pyoderma Gangrenosum | 1 | 2019 | 84 | 0.600 |
Why?
|
Enterobacteriaceae Infections | 1 | 2020 | 187 | 0.590 |
Why?
|
Abortion, Spontaneous | 1 | 2022 | 533 | 0.570 |
Why?
|
Cesarean Section | 3 | 2024 | 1399 | 0.570 |
Why?
|
Debridement | 1 | 2019 | 493 | 0.540 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 983 | 0.530 |
Why?
|
Carrier State | 1 | 2020 | 522 | 0.520 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.410 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2021 | 2150 | 0.390 |
Why?
|
Lung Transplantation | 1 | 2021 | 1307 | 0.390 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1878 | 0.350 |
Why?
|
Influenza, Human | 1 | 2021 | 1521 | 0.350 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 1462 | 0.340 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 1530 | 0.340 |
Why?
|
Alkanesulfonic Acids | 2 | 2023 | 201 | 0.330 |
Why?
|
Gynecology | 2 | 2023 | 528 | 0.280 |
Why?
|
Fluorocarbons | 2 | 2023 | 492 | 0.270 |
Why?
|
Pregnancy | 11 | 2024 | 29893 | 0.270 |
Why?
|
Obstetrics | 2 | 2023 | 668 | 0.260 |
Why?
|
Infant, Newborn | 7 | 2024 | 26199 | 0.230 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2023 | 107 | 0.210 |
Why?
|
Menopause, Premature | 1 | 2023 | 124 | 0.200 |
Why?
|
Austria | 4 | 2023 | 206 | 0.200 |
Why?
|
Rheumatic Fever | 1 | 2021 | 73 | 0.180 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1032 | 0.170 |
Why?
|
beta-Lactam Resistance | 1 | 2020 | 73 | 0.170 |
Why?
|
Streptococcus agalactiae | 1 | 2020 | 337 | 0.160 |
Why?
|
Enterobacteriaceae | 1 | 2020 | 161 | 0.150 |
Why?
|
Labor, Obstetric | 1 | 2021 | 323 | 0.150 |
Why?
|
Klebsiella pneumoniae | 1 | 2020 | 249 | 0.150 |
Why?
|
beta-Lactamases | 1 | 2020 | 304 | 0.150 |
Why?
|
Antifungal Agents | 1 | 2022 | 752 | 0.140 |
Why?
|
Probiotics | 1 | 2020 | 378 | 0.140 |
Why?
|
Streptococcal Infections | 1 | 2020 | 617 | 0.130 |
Why?
|
Pregnancy Outcome | 2 | 2023 | 2923 | 0.120 |
Why?
|
Salvage Therapy | 1 | 2021 | 1264 | 0.120 |
Why?
|
Female | 15 | 2024 | 392544 | 0.120 |
Why?
|
HIV Infections | 1 | 2021 | 17347 | 0.110 |
Why?
|
Environmental Pollutants | 1 | 2023 | 1276 | 0.110 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 845 | 0.100 |
Why?
|
Switzerland | 2 | 2023 | 319 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1265 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2244 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7407 | 0.090 |
Why?
|
Germany | 2 | 2023 | 872 | 0.090 |
Why?
|
Education, Medical | 1 | 2022 | 1725 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2023 | 2517 | 0.090 |
Why?
|
Case-Control Studies | 3 | 2023 | 22174 | 0.080 |
Why?
|
Humans | 15 | 2024 | 761208 | 0.080 |
Why?
|
Clinical Competence | 1 | 2023 | 4788 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14610 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2421 | 0.070 |
Why?
|
Adult | 6 | 2023 | 221119 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12976 | 0.060 |
Why?
|
Alkanesulfonates | 1 | 2023 | 15 | 0.050 |
Why?
|
Internship and Residency | 1 | 2023 | 5885 | 0.050 |
Why?
|
Placenta | 2 | 2023 | 1711 | 0.050 |
Why?
|
Prospective Studies | 2 | 2024 | 54435 | 0.050 |
Why?
|
Serum | 1 | 2021 | 208 | 0.040 |
Why?
|
Labor, Induced | 1 | 2021 | 152 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 982 | 0.040 |
Why?
|
Self Concept | 1 | 2023 | 1046 | 0.040 |
Why?
|
Risk Factors | 2 | 2021 | 74239 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 568 | 0.030 |
Why?
|
Autoimmunity | 1 | 2023 | 1356 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2119 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 80674 | 0.030 |
Why?
|
Birth Weight | 1 | 2021 | 2104 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4015 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2019 | 64681 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2374 | 0.020 |
Why?
|
Sex Factors | 1 | 2023 | 10553 | 0.020 |
Why?
|
Cohort Studies | 1 | 2021 | 41496 | 0.010 |
Why?
|
Male | 1 | 2023 | 360693 | 0.000 |
Why?
|